Avemar has been recognised and studied worldwide since 1998. As in vitro, in vivo and clinical studies provided further evidence of its safety and effectiveness in the supplementation of oncological treatments, Avemar was registered as “dietary food for special medical purposes for cancer patients” in 2002. Since the discovery of Avemar pulvis, the active ingredient […]
